or Try an Advanced Search...

    Immunotherapy Products Stocks List

    Symbol Grade Name % Change
    ADAP D Adaptimmune Therapeutics plc -1.75
    DBVT F DBV Technologies S.A. 0.96
    IOVA D Iovance Biotherapeutics, Inc. -18.48
    MBIO F Mustang Bio, Inc. -3.77
    REPL F Replimune Group, Inc. -4.75
    TCBP F TC BioPharm (Holdings) plc -6.56
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Immunotherapy Cancer Treatment Immune System Medicine Biopharmaceutical Cancer Cancer Immunotherapy Solid Tumors Cancer Immunotherapy Product Clinical Medicine Virotherapy Adoptive Cell Transfer Biotechnology Breast And Lung Cancer Cancer Cell Cell Therapy Melanoma Acid Acute Myeloid Leukemia Akseli Hemminki

    Related ETFs - A few ETFs which own one or more of the above listed Immunotherapy Products stocks.

    Symbol Grade Name Weight
    IDNA C iShares Genomics Immunology and Healthcare ETF 3.32
    WDNA D WisdomTree BioRevolution Fund 2.61
    CNCR D Loncar Cancer Immunotherapy ETF 2.11
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 2.06
    INNO D Harbor Disruptive Innovation ETF 1.79
    View all Immunotherapy Products ETFs...
    Compare ETFs
    Compare BBC to INNO Compare CNCR to BBC Compare IDNA to CNCR

        Immunotherapy Products Stocks Recent News

        Date Stock Title
        May 10 IOVA Iovance Q1 Earnings Review: Not Enough Data To Draw Conclusions On Amtagvi
        May 10 IOVA Why Iovance Stock Is Down 18% Today
        May 10 IOVA Iovance Biotherapeutics' Patient Selection for Amtagvi Launch Minimizing Attrition, Truist Securities Says
        May 10 IOVA Iovance Biotherapeutics Inc (IOVA) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strong ...
        May 10 IOVA Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript
        May 10 IOVA Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
        May 10 IOVA Iovance Biotherapeutics, Inc. (IOVA) Q1 2024 Earnings Call Transcript
        May 9 DBVT DBV Technologies to Participate in Upcoming Investor Conferences
        May 9 IOVA Iovance Biotherapeutics reports Q1 results
        May 9 IOVA Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
        May 9 IOVA How Is The Market Feeling About Iovance Biotherapeutics?
        May 8 IOVA Iovance Biotherapeutics Q1 2024 Earnings Preview
        May 7 DBVT DBV Technologies GAAP EPS of -$0.28
        May 7 DBVT DBV Technologies Reports First Quarter 2024 Financial Results and Business Update
        May 6 TCBP TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds
        May 6 IOVA Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
        May 6 IOVA Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect
        May 6 TCBP TC Biopharm executes second LOI to buy CAR-T therapies, shares up
        May 6 TCBP TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies
        Related Industries: Biotechnology
        Related Stock Lists: Immunotherapy Cancer Treatment Immune System Medicine Biopharmaceutical Cancer Cancer Immunotherapy Solid Tumors Cancer Immunotherapy Product Clinical Medicine Virotherapy Adoptive Cell Transfer Biotechnology Breast And Lung Cancer Cancer Cell Cell Therapy Melanoma Acid Acute Myeloid Leukemia Akseli Hemminki
        Immunotherapy Products

        Immunotherapy products are treatments that use the body’s own immune system to fight disease. They can be used to treat cancer, autoimmune diseases, and other conditions. Immunotherapy products can be made from proteins, antibodies, or other substances that stimulate the body’s immune system to recognize and attack cancer cells or other abnormal cells. They can also be used to boost the body’s natural defenses against infection.

        Browse All Tags